Tony Papenfuss

50PUBLICATIONS
421CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisAutomated software engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jun 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

|Jun 17, 2026
The Landscape of Prostate Tumour Methylation.

|Nov 05, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

|Aug 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.

Margaret A Potts, Shinsuke Mizutani, Yexuan Deng

|Feb 13, 2025
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Takafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu

|Aug 21, 2024
Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma.

Richard A Sturm, Darren J Smit, David L Duffy

Pageof 9

Frequent Collaborators

11 joint publications

Stefano Mangiola

8 joint publications

Daniel L Cameron

7 joint publications

Jocelyn Sietsma Penington

5 joint publications

Justin Bedo